| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |